Retrospective Study
Copyright ©The Author(s) 2018.
World J Gastrointest Oncol. Dec 15, 2018; 10(12): 487-495
Published online Dec 15, 2018. doi: 10.4251/wjgo.v10.i12.487
Table 1 Characteristics of enrolled patients before propensity score matching
ESD-C n = 50ESD-O n = 105P valueASD
Age, yr
Mean ± SD73.1 ± 8.5572.75 ± 8.040.80620.0422
Median (range)74.0 (46–91)73.0 (52–91)0.5803
Sex (n)
Male39710.25610.2350
Female1134
Underlying disease, positive, n (%)18 (36.0)29 (27.6)0.35010.1810
Anti-thrombotic drugs (n)
None or discontinuation481020.65810.0623
Continuation23
Tumor location (n)
Upper third9170.82010.0481
Middle or lower third4188
Tumor position (n)
Lessor21570.73110.2670
Others2948
Morphology (n)
Flat or depressed29630.86210.0407
Others2142
Histology (n)
Undifferentiated510.014140.4060
Others45104
Tumor size (mm)
Mean ± SD16.89 ± 12.6520.90 ± 13.300.07620.3090
Median (range)13.5 (3–67)18.0 (3–82)0.02734
Tumor depth (n)
Mucosa44911.00010.0401
Submucosa614
Ulceration positive, n (%)7 (14.0)22 (21.0)0.38110.1840
Operator skill
Experts34730.85410.0329
Trainees1632